New Insights into FoxE1 Functions: Identification of Direct FoxE1 Targets in Thyroid Cells

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Fernández, Lara P ^a   López Márquez, Arístides ^a   Martínez, Ángel M ^a,b   Gómez López, Gonzalo ^b   Santisteban, Pilar ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Structural Biology and Biocomputing Programme   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXE1; TRANSCRIPTION FACTOR NF1; UNCLASSIFIED DRUG;

ADAMTS9 GENE; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CASP4 GENE; CDH1 GENE; COMPUTER MODEL; CONTROLLED STUDY; CRELD2 GENE; DOWN REGULATION; DUOX2 GENE; DUSP5 GENE; ENHANCER REGION; ETV5 GENE; FOXE1 GENE; GENE; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENETIC SCREENING; GENOME ANALYSIS; HSP5A GENE; HUMAN; HUMAN CELL; IN VIVO STUDY; NIS GENE; NONHUMAN; NR4A2 GENE; NUCLEOTIDE SEQUENCE; PAX8 GENE; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN TARGETING; RAT; S100A4 GENE; THYROID FOLLICLE CELL; TITF1 GENE; TM4SF1 GENE; UPREGULATION; VALIDATION PROCESS;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; FLAVOPROTEINS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SYMPORTERS; THYROID GLAND; TRANSCRIPTION, GENETIC;

EID: 84877692624     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062849     Document Type: Article

References (51)

1. Damante G, Tell G, Di Lauro R, (2001) A unique combination of transcription factors controls differentiation of thyroid cells. Prog Nucleic Acid Res Mol Biol 66: 307-356.
2. De Felice M, Di Lauro R, (2004) Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 25: 722-746.
3. Zannini M, Avantaggiato V, Biffali E, Arnone MI, Sato K, et al. (1997) TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J 16: 3185-3197.
4. Myatt SS, Lam EW, (2007) The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 7: 847-859.
5. Carlsson P, Mahlapuu M, (2002) Forkhead transcription factors: key players in development and metabolism. Dev Biol 250: 1-23.
6. Cuesta I, Zaret KS, Santisteban P, (2007) The forkhead factor FoxE1 binds to the thyroperoxidase promoter during thyroid cell differentiation and modifies compacted chromatin structure. Mol Cell Biol 27: 7302-7314.
7. Zaret KS, Carroll JS, (2011) Pioneer transcription factors: establishing competence for gene expression. Genes Dev 25: 2227-2241.
8. De Felice M, Ovitt C, Biffali E, Rodriguez-Mallon A, Arra C, et al. (1998) A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet 19: 395-398.
9. Bamforth JS, Hughes IA, Lazarus JH, Weaver CM, Harper PS, (1989) Congenital hypothyroidism, spiky hair, and cleft palate. J Med Genet 26: 49-51.
10. Clifton-Bligh RJ, Wentworth JM, Heinz P, Crisp MS, John R, et al. (1998) Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet 19: 399-401.
11. Venza I, Visalli M, Tripodo B, Lentini M, Teti D, et al. (2009) Investigation into FOXE1 genetic variations in cutaneous squamous cell carcinoma. Br J Dermatol 162: 681-683.
12. Venza I, Visalli M, Tripodo B, De Grazia G, Loddo S, et al. (2009) FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma. Br J Dermatol 162: 1093-1097.
13. Brune K, Hong SM, Li A, Yachida S, Abe T, et al. (2008) Genetic and epigenetic alterations of familial pancreatic cancers. Cancer Epidemiol Biomarkers Prev 17: 3536-3542.
14. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, et al. (2009) Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41: 460-464.
15. Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Perez L, Schiavi F, et al. (2009) The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 5: e1000637.
16. Bullock M, Duncan EL, O'Neill C, Tacon L, Sywak M, et al. (2012) Association of FOXE1 Polyalanine Repeat Region with Papillary Thyroid Cancer. J Clin Endocrinol Metab 97: E1814-1819.
17. Santisteban P, Acebron A, Polycarpou-Schwarz M, Di Lauro R, (1992) Insulin and insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter. Mol Endocrinol 6: 1310-1317.
18. Aza-Blanc P, Di Lauro R, Santisteban P, (1993) Identification of a cis-regulatory element and a thyroid-specific nuclear factor mediating the hormonal regulation of rat thyroid peroxidase promoter activity. Mol Endocrinol 7: 1297-1306.
19. Perrone L, Pasca di Magliano M, Zannini M, Di Lauro R, (2000) The thyroid transcription factor 2 (TTF-2) is a promoter-specific DNA-binding independent transcriptional repressor. Biochem Biophys Res Commun 275: 203-208.
20. Francis-Lang H, Price M, Polycarpou-Schwarz M, Di Lauro R, (1992) Cell-type-specific expression of the rat thyroperoxidase promoter indicates common mechanisms for thyroid-specific gene expression. Mol Cell Biol 12: 576-588.
21. Ortiz L, Aza-Blanc P, Zannini M, Cato AC, Santisteban P, (1999) The interaction between the forkhead thyroid transcription factor TTF-2 and the constitutive factor CTF/NF-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription. J Biol Chem 274: 15213-15221.
22. Hishinuma A, Ohmika N, Namatame T, Ieiri T, (2004) TTF-2 stimulates expression of 17 genes, including one novel thyroid-specific gene which might be involved in thyroid development. Mol Cell Endocrinol 221: 33-46.
23. Venza I, Visalli M, Parrillo L, De Felice M, Teti D, et al. (2010) MSX1 and TGF-beta3 are novel target genes functionally regulated by FOXE1. Hum Mol Genet 20: 1016-1025.
24. Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M, et al. (1987) One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol 7: 3365-3370.
25. Costamagna E, Garcia B, Santisteban P, (2004) The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene. J Biol Chem 279: 3439-3446.
26. Medina DL, Santisteban P, (2000) Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems. Eur J Endocrinol 143: 161-178.
27. Al-Shahrour F, Minguez P, Tarraga J, Medina I, Alloza E, et al. (2007) FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments. Nucleic Acids Res 35: W91-96.
28. Medina I, Carbonell J, Pulido L, Madeira SC, Goetz S, et al. (2010) Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 38: W210-213.
29. De la Vieja A, Reed MD, Ginter CS, Carrasco N, (2007) Amino acid residues in transmembrane segment IX of the Na+/I- symporter play a role in its Na+ dependence and are critical for transport activity. J Biol Chem 282: 25290-25298.
30. Dupuy C, Pomerance M, Ohayon R, Noel-Hudson MS, Deme D, et al. (2000) Thyroid oxidase (THOX2) gene expression in the rat thyroid cell line FRTL-5. Biochem Biophys Res Commun 277: 287-292.
31. Ruiz-Llorente S, Carrillo Santa de Pau E, Sastre-Perona A, Montero-Conde C, Gomez-Lopez G, et al. (2012) Genome-wide analysis of Pax8 binding provides new insights into thyroid functions. BMC Genomics 13: 147.
32. Garcia B, Santisteban P, (2002) PI3K is involved in the IGF-I inhibition of TSH-induced sodium/iodide symporter gene expression. Mol Endocrinol 16: 342-352.
33. Nebl G, Cato AC, (1995) NFI/X proteins: a class of NFI family of transcription factors with positive and negative regulatory domains. Cell Mol Biol Res 41: 85-95.
34. Jackson DA, Rowader KE, Stevens K, Jiang C, Milos P, et al. (1993) Modulation of liver-specific transcription by interactions between hepatocyte nuclear factor 3 and nuclear factor 1 binding DNA in close apposition. Mol Cell Biol 13: 2401-2410.
35. Ohno M, Zannini M, Levy O, Carrasco N, di Lauro R, (1999) The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol Cell Biol 19: 2051-2060.
36. Pierrou S, Hellqvist M, Samuelsson L, Enerback S, Carlsson P, (1994) Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. EMBO J 13: 5002-5012.
37. Bjorkman U, Ekholm R, Denef JF, (1981) Cytochemical localization of hydrogen peroxide in isolated thyroid follicles. J Ultrastruct Res 74: 105-115.
38. Bjorkman U, Ekholm R, (1984) Generation of H2O2 in isolated porcine thyroid follicles. Endocrinology 115: 392-398.
39. Dupuy C, Ohayon R, Valent A, Noel-Hudson MS, Deme D, et al. (1999) Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cdnas. J Biol Chem 274: 37265-37269.
40. Christophe-Hobertus C, Christophe D, (2007) Human Thyroid Oxidases genes promoter activity in thyrocytes does not appear to be functionally dependent on Thyroid Transcription Factor-1 or Pax8. Mol Cell Endocrinol 264: 157-163.
41. Moreno JC, Bikker H, Kempers MJ, van Trotsenburg AS, Baas F, et al. (2002) Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 347: 95-102.
42. Vigone MC, Fugazzola L, Zamproni I, Passoni A, Di Candia S, et al. (2005) Persistent mild hypothyroidism associated with novel sequence variants of the DUOX2 gene in two siblings. Hum Mutat 26: 395.
43. D'Andrea B, Iacone R, Di Palma T, Nitsch R, Baratta MG, et al. (2006) Functional inactivation of the transcription factor Pax8 through oligomerization chain reaction. Mol Endocrinol 20: 1810-1824.
44. Park E, Gong EY, Romanelli MG, Lee K, (2012) Suppression of estrogen receptor-alpha transactivation by thyroid transcription factor-2 in breast cancer cells. Biochem Biophys Res Commun 421: 532-537.
45. Wang B, Lin D, Li C, Tucker P, (2003) Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J Biol Chem 278: 24259-24268.
46. Yap AS, Stevenson BR, Keast JR, Manley SW, (1995) Cadherin-mediated adhesion and apical membrane assembly define distinct steps during thyroid epithelial polarization and lumen formation. Endocrinology 136: 4672-4680.
47. Brabant G, Hoang-Vu C, Behrends J, Cetin Y, Potter E, et al. (1995) Regulation of the cell-cell adhesion protein, E-cadherin, in dog and human thyrocytes in vitro. Endocrinology 136: 3113-3119.
48. Ortiz L, Zannini M, Di Lauro R, Santisteban P, (1997) Transcriptional control of the forkhead thyroid transcription factor TTF-2 by thyrotropin, insulin, and insulin-like growth factor I. J Biol Chem. 272: 23334-23339.
49. Maijenburg MW, Gilissen C, Melief SM, Kleijer M, Weijer K, et al. (2011) Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration. Stem Cells Dev 21: 228-238.
50. Lee HS, Bae EJ, Yi SH, Shim JW, Jo AY, et al. (2010) Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival. Stem Cells 28: 501-512.
51. Li W, Ain KB, (2010) Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells. Endocr Relat Cancer 17: 383-398.